| MeSH term | MeSH ID | Detail |
|---|---|---|
| Vestibulocochlear Nerve Diseases | D000160 | 1 associated lipids |
| Acromegaly | D000172 | 6 associated lipids |
| Actinobacillus Infections | D000189 | 4 associated lipids |
| Actinomycosis | D000196 | 2 associated lipids |
| Addison Disease | D000224 | 3 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Adrenal Hyperplasia, Congenital | D000312 | 2 associated lipids |
| Albuminuria | D000419 | 18 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
| Angioid Streaks | D000793 | 1 associated lipids |
| Ankylosis | D000844 | 1 associated lipids |
| Aortic Diseases | D001018 | 11 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Arthritis, Experimental | D001169 | 24 associated lipids |
| Arthritis, Rheumatoid | D001172 | 3 associated lipids |
| Arthropathy, Neurogenic | D001177 | 1 associated lipids |
| Atrial Fibrillation | D001281 | 16 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Jørgensen L et al. | Osteoprotegerin is associated with hip fracture incidence: the Tromso Study. | 2012 | Int J Epidemiol | pmid:22538253 |
| Feng Q et al. | [Effect of sonicated extracts of Porphyromonas gingivalis on receptor activator of NF-κB ligand and osteoprotegerin expression in periodontal ligament cells]. | 2012 | Zhonghua Kou Qiang Yi Xue Za Zhi | pmid:23302383 |
| Terpos E et al. | Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis. | 2011 Nov-Dec | Clin. Exp. Rheumatol. | pmid:22032557 |
| Arikan F et al. | C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study. | 2011 Mar-Apr | Int J Oral Maxillofac Implants | pmid:21483881 |
| Crespi R et al. | Corticocancellous porcine bone in the healing of human extraction sockets: combining histomorphometry with osteoblast gene expression profiles in vivo. | 2011 Jul-Aug | Int J Oral Maxillofac Implants | pmid:21841997 |
| Franke S et al. | Advanced glycation end products affect growth and function of osteoblasts. | 2011 Jul-Aug | Clin. Exp. Rheumatol. | pmid:21906430 |
| Rezg R et al. | Inhibitors of vascular calcification as potential therapeutic targets. | 2011 Jul-Aug | J. Nephrol. | pmid:21688249 |
| Reyes-GarcÃa R et al. | [Cardiovascular disease and bone metabolism]. | 2011 Aug-Sep | Endocrinol Nutr | pmid:21775224 |
| Wang Y et al. | LC, a novel estrone-rhein hybrid compound, concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production by human osteoblastic cells. | 2011 | Mol. Cell. Endocrinol. | pmid:21291955 |
| Szulc P et al. | Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study. | 2011 | J. Clin. Endocrinol. Metab. | pmid:21565793 |
| Zhang Y et al. | Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone. | 2011 | PLoS ONE | pmid:21897843 |
| Chang YC and Zhao JH | Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for periodontal infrabony defects. | 2011 | Aust Dent J | pmid:22126345 |
| Yang L et al. | Osteoprotegerin and osteoprotegerin ligand expression during human marrow stromal cell differentiation and their effect on osteoclast formation. | 2011 | Chin. Med. J. | pmid:22088466 |
| Curl L and Sampson W | The presence of TNF-alpha and TNFR1 in aseptic root resorption. A preliminary study. | 2011 | Aust Orthod J | pmid:22372265 |
| Yamamoto K et al. | Effects of mechanical stress on cytokine production in mandible-derived osteoblasts. | 2011 | Oral Dis | pmid:21771211 |
| Chen WJ et al. | Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men. | 2011 | Cardiovasc Diabetol | pmid:21771299 |
| Pepene CE et al. | Elevated serum receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in late-onset male hypogonadism. | 2011 | Clin Invest Med | pmid:21810381 |
| Sheng L et al. | [Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system]. | 2011 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:21812275 |
| Yang XY et al. | [Influence of surface modification of titanium on OPG/RANKL mRNA expression in MG-63 human osteoblast-like cells]. | 2011 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:21868322 |
| Malliga DE et al. | The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review. | 2011 | Wien Med Wochenschr | pmid:21870142 |
| Guo HL et al. | [Experimental study on the mechanism of icariin improving human osteoblasts proliferation and the expression of OPG protein]. | 2011 | Zhongguo Gu Shang | pmid:21870401 |
| Mohamed GB and Abdel-Latif EA | Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome. | 2011 | Saudi J Kidney Dis Transpl | pmid:21912025 |
| Lommi JI et al. | High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification. | 2011 | Atherosclerosis | pmid:21917259 |
| Embree M et al. | Role of subchondral bone during early-stage experimental TMJ osteoarthritis. | 2011 | J. Dent. Res. | pmid:21917603 |
| Hope S et al. | Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. | 2011 | J Psychiatr Res | pmid:21889167 |
| Shin M et al. | The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. | 2011 | Carcinogenesis | pmid:21890459 |
| Grigoropoulou P et al. | The role of the osteoprotegerin/RANKL/RANK system in diabetic vascular disease. | 2011 | Curr. Med. Chem. | pmid:21919846 |
| Riancho JA and Delgado-Calle J | [Osteoblast-osteoclast interaction mechanisms]. | 2011 | Reumatol Clin | pmid:21924211 |
| To M et al. | Osteoprotegerin in sputum is a potential biomarker in COPD. | 2011 | Chest | pmid:21127170 |
| Witasp A et al. | Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease. | 2011 | Eur. J. Clin. Invest. | pmid:21128937 |
| Khoshniat S et al. | Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium. | 2011 | Bone | pmid:21147284 |
| Durual S et al. | Titanium nitride oxide coating on rough titanium stimulates the proliferation of human primary osteoblasts. | 2011 | Clin Oral Implants Res | pmid:21087318 |
| Ashley DT et al. | Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects. | 2011 | Metab. Clin. Exp. | pmid:21087777 |
| Tekkesin MS et al. | The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas. | 2011 | Head Neck Pathol | pmid:21643971 |
| Jiang JQ et al. | Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder. | 2011 | Nephrology (Carlton) | pmid:21649792 |
| Choi EM | Honokiol isolated from Magnolia officinalis stimulates osteoblast function and inhibits the release of bone-resorbing mediators. | 2011 | Int. Immunopharmacol. | pmid:21621646 |
| Ueland T et al. | Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis. | 2011 | J. Intern. Med. | pmid:21623962 |
| Hossein-nezhad A et al. | The influence of folic acid supplementation on maternal and fetal bone turnover. | 2011 | J. Bone Miner. Metab. | pmid:20602129 |
| Colombini A et al. | Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing. | 2011 | Int Orthop | pmid:20623281 |
| Krause U et al. | Assays of osteogenic differentiation by cultured human mesenchymal stem cells. | 2011 | Methods Mol. Biol. | pmid:21431522 |
| Clemens TL and Karsenty G | The osteoblast: an insulin target cell controlling glucose homeostasis. | 2011 | J. Bone Miner. Res. | pmid:21433069 |
| Kanayama K et al. | Osteoclast and osteoblast activities on carbonate apatite plates in cell cultures. | 2011 | J Biomater Appl | pmid:20624844 |
| Galliera E et al. | Circulating OPG levels are reduced following infliximab treatment and correlate with CRP levels: is serum OPG a potential marker of IBD disease activity? | 2011 | Inflamm. Bowel Dis. | pmid:21433226 |
| Hou L et al. | Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts. | 2011 | Acta Vet. Scand. | pmid:21435269 |
| Baloul SS et al. | Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. | 2011 | Am J Orthod Dentofacial Orthop | pmid:21435543 |
| Wang AY | Consequences of chronic inflammation in peritoneal dialysis. | 2011 | Semin. Nephrol. | pmid:21439430 |
| Ikeda K et al. | Conditional expression of constitutively active estrogen receptor α in osteoblasts increases bone mineral density in mice. | 2011 | FEBS Lett. | pmid:21439958 |
| Teramachi J et al. | Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis. | 2011 | Lab. Invest. | pmid:21339747 |
| Katz J et al. | Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. | 2011 | Int J Oral Maxillofac Surg | pmid:21396799 |
| Bitto A et al. | Genistein aglycone effect on bone loss is not enhanced by supplemental calcium and vitamin D3: a dose ranging experimental study. | 2011 | Phytomedicine | pmid:21397481 |
| Vishvanath A et al. | Infantile haemangioma expresses tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, osteoprotegerin and receptor activator for nuclear factor кB ligand (RANKL). | 2011 | Histopathology | pmid:22034880 |
| Vidal C et al. | Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density. | 2011 | J. Mol. Endocrinol. | pmid:21994215 |
| Hemingway F et al. | In vitro generation of mature human osteoclasts. | 2011 | Calcif. Tissue Int. | pmid:21960377 |
| Dimitriadis K et al. | Exercise blood pressure response is related to asymmetric dimethylarginine and osteoprotegerin in hypertension. | 2011 | Int. J. Cardiol. | pmid:21975354 |
| Yao Y et al. | Synergistic enhancement of new bone formation by recombinant human bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis: a pilot study in dogs. | 2011 | J. Oral Maxillofac. Surg. | pmid:22018252 |
| Brown TT et al. | Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens. | 2011 | Antivir. Ther. (Lond.) | pmid:22024522 |
| Mödder UI et al. | Regulation of circulating sclerostin levels by sex steroids in women and in men. | 2011 | J. Bone Miner. Res. | pmid:20499362 |
| Hsieh TP et al. | Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. | 2011 | Phytomedicine | pmid:20554188 |
| Al-Dujaili SA et al. | Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro. | 2011 | J. Cell. Biochem. | pmid:21538477 |
| Stępień E et al. | Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals. | 2011 | Clin. Biochem. | pmid:21539822 |
| Zheng Y et al. | Vitamin D deficiency promotes prostate cancer growth in bone. | 2011 | Prostate | pmid:21541977 |
| Yener S et al. | Is there an association between non-functioning adrenal adenoma and endothelial dysfunction? | 2011 | J. Endocrinol. Invest. | pmid:20530985 |
| de Souza JA et al. | Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats. | 2011 | Arch. Oral Biol. | pmid:21511249 |
| Claro T et al. | Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. | 2011 | PLoS ONE | pmid:21525984 |
| Giro G et al. | Influence of estrogen deficiency on bone around osseointegrated dental implants: an experimental study in the rat jaw model. | 2011 | J. Oral Maxillofac. Surg. | pmid:21530046 |
| Won KY et al. | RANK signalling in bone lesions with osteoclast-like giant cells. | 2011 | Pathology | pmid:21532526 |
| Naot D et al. | Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts. | 2011 | Bone | pmid:21515435 |
| Aydin H et al. | Effect of oxidative stress on aorta and tibia osteoprotegerin gene expression in ovariectomized rats. | 2011 | Minerva Endocrinol. | pmid:21519319 |
| Halade GV et al. | Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. | 2011 | Exp. Gerontol. | pmid:20923699 |
| Mitsuhashi M et al. | Effects of HSP70 on the compression force-induced TNF-α and RANKL expression in human periodontal ligament cells. | 2011 | Inflamm. Res. | pmid:20924639 |
| Huang CH et al. | Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis. | 2011 | Rheumatology (Oxford) | pmid:20974615 |
| Pepene CE et al. | Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction. | 2011 | Eur. J. Endocrinol. | pmid:20974706 |
| Kassi E et al. | Effects of Sideritis euboea (Lamiaceae) aqueous extract on IL-6, OPG and RANKL secretion by osteoblasts. | 2011 | Nat Prod Commun | pmid:22224290 |
| Sipos W et al. | OPG-Fc treatment in growing pigs leads to rapid reductions in bone resorption markers, serum calcium, and bone formation markers. | 2011 | Horm. Metab. Res. | pmid:22161252 |
| Vik A et al. | Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study. | 2011 | J. Thromb. Haemost. | pmid:21284802 |
| Akinci B et al. | Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome. | 2011 | Diabetes Res. Clin. Pract. | pmid:20970873 |
| Hasegawa T et al. | [Animal models for bone and joint disease. Bone disease of osteoprotegerin deficient mouse]. | 2011 | Clin Calcium | pmid:21289415 |
| Toffoli B et al. | Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. | 2011 | Mol. Cell. Endocrinol. | pmid:20832449 |
| Qu Z et al. | Effect of enamel matrix derivative on proliferation and differentiation of osteoblast cells grown on the titanium implant surface. | 2011 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:21232997 |
| Rauch A et al. | An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. | 2011 | FASEB J. | pmid:21233489 |
| Ueland T et al. | Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. | 2011 | Circ Heart Fail | pmid:21216833 |
| Tang T et al. | Effect of water-soluble P-chitosan and S-chitosan on human primary osteoblasts and giant cell tumor of bone stromal cells. | 2011 | Biomed Mater | pmid:21205994 |
| Attia EA et al. | Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity. | 2011 | Int. J. Dermatol. | pmid:21182499 |
| Polzer K et al. | Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis. | 2011 | Arthritis Rheum. | pmid:21360496 |
| Oshita K et al. | Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. | 2011 | Arthritis Rheum. | pmid:21360521 |
| Wang SY et al. | Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis. | 2011 | J. Rheumatol. | pmid:21362762 |
| Preshaw PM and Taylor JJ | How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? | 2011 | J. Clin. Periodontol. | pmid:21323705 |
| Basu R et al. | Effects of physiological variations in circulating insulin levels on bone turnover in humans. | 2011 | J. Clin. Endocrinol. Metab. | pmid:21325461 |
| Kamiya N et al. | Significance of serum osteoprotegerin and receptor activator of nuclear factor κB ligand in Japanese prostate cancer patients with bone metastasis. | 2011 | Int. J. Clin. Oncol. | pmid:21327451 |
| Eslami B et al. | Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate. | 2011 | Calcif. Tissue Int. | pmid:21327765 |
| Blázquez-Medela AM et al. | Osteoprotegerin and diabetes-associated pathologies. | 2011 | Curr. Mol. Med. | pmid:21568931 |
| Jørgensen L et al. | Serum osteoprotegerin levels are related to height loss: the Tromsø Study. | 2011 | Eur. J. Epidemiol. | pmid:21331661 |
| Yuan H et al. | Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis. | 2011 | J. Clin. Periodontol. | pmid:22092474 |
| Feng Z et al. | An oligodeoxynucleotide with promising modulation activity for the proliferation and activation of osteoblast. | 2011 | Int J Mol Sci | pmid:21731457 |
| Peng S et al. | Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption. | 2011 | J. Bone Miner. Res. | pmid:21611968 |
| Mai QG et al. | Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. | 2011 | J. Cell. Biochem. | pmid:21618594 |
| Garcia VG et al. | Treatment of experimental periodontal disease with antimicrobial photodynamic therapy in nicotine-modified rats. | 2011 | J. Clin. Periodontol. | pmid:22092666 |
| Kornak U | Animal models with pathological mineralization phenotypes. | 2011 | Joint Bone Spine | pmid:21550285 |
| Santini D et al. | Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. | 2011 | PLoS ONE | pmid:21559440 |
| Mariúba MV et al. | Effect of triiodothyronine on the maxilla and masseter muscles of the rat stomatognathic system. | 2011 | Braz. J. Med. Biol. Res. | pmid:21584440 |